Key terms

About TLRY

Tilray Brands, Inc. is a global cannabis-lifestyle and consumer packaged goods company, which focuses on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. It operates through the followings segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, and Wellness Business. The Cannabis Business segment focuses on cultivation, production, distribution, and sale of both medical and adult-use cannabis products. The Distribution Business segment is involved in purchase, resale, and distribution of pharmaceutical and wellness products. The Beverage Alcohol Business segment refers to the production, marketing, and sale of beverages. The Wellness Business segment represents the production, marketing, and distribution of hemp-based food and other wellness products. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
     
52-week range
     
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date

Key terms

Smart score

Latest TLRY news

Nov 21 11:05am ET Rising High: Numinus Wellness to sell five Utah clinics for $3.53M Nov 21 8:16am ET Redhook Brewery, Montlake Futures partner for Montlake Gameday Gold Lager Nov 21 7:40am ET Tilray launches 2024 Holiday Cannabis Gift Guide Nov 21 7:14am ET Tilray Brands presents 2024 holiday spirits, craft beverage gift guide Nov 14 12:30pm ET Rising High: Cannabis firms report quarterly earnings Nov 14 7:50am ET Tilray’s Blue Point Brewing expands winter seasonal lineup Nov 14 7:36am ET Tilray Medical launches first commercial German grown medical cannabis products Nov 13 7:51am ET Tilray’s 10 Barrel Brewing announces 13th Annual Pray for Snow Party Nov 13 7:42am ET Tilray’s Breckenridge Brewery releases Candy Cane Vodka Nov 12 8:06am ET Tilray’s SweetWater Brewing unveils headliners for 420 Fest Nov 07 11:25am ET Rising High: Exclusive talk with house of brands Carma HoldCo Nov 07 8:06am ET Tilray launches new podcast series to break down stigmas around men’s health Nov 07 7:57am ET Tilray Medical announces results from study on oral cannabis extract Oct 31 10:30am ET Rising High: Compass Pathways reports Q3 earnings Oct 31 7:26am ET Tilray’s Breckenridge announces collaboration with University of Colorado Oct 29 7:21am ET Tilray subsidiary releases new creation, Dad’s Stash Whiskey Oct 24 10:30am ET Rising High: RIV Capital provides update on revenue, synergy realization Oct 22 7:21am ET Tilray’s Blue Point announces men’s health awareness campaign Oct 21 7:26am ET Tilray’s Breckenridge Brewery releases seasonal Funslinger Lager Oct 17 11:05am ET Rising High: Exclusive talk with vape tech developer Ispire Technology Oct 17 7:10am ET Tilray celebrates six years of cannabis legalization in Canada Oct 14 8:01am ET Tilray (TLRY) Expects to Benefit from Cannabis-Friendly Regulations Oct 13 10:55am ET Tilray’s Strategic Investments Prompt ‘Hold’ Rating Amid EBITDA Pressure and Industry Uncertainty Oct 13 2:01am ET Tilray’s Post-Acquisition Roadblocks: Balancing Growth and Integration Challenges Oct 11 10:05am ET Tilray’s Strategic Focus and Beverage Growth Potential Justify Buy Rating Despite Lowered Price Target Oct 11 8:15am ET Tilray price target lowered to $1.75 from $2 at Roth MKM Oct 11 7:55am ET Tilray’s Stagnant Organic Growth and Market Uncertainties Prompt Continued Hold Rating Oct 11 6:36am ET Tilray (TLRY) Receives a Hold from Piper Sandler Oct 10 5:35pm ET Tilray price target lowered to $1.75 from $2.25 at Alliance Global Partners Oct 10 11:55am ET Delta reports mixed Q3, Domino’s reports earnings beat: Morning Buzz Oct 10 10:05am ET Rising High: Exclusive talk with cannabis REIT NewLake Capital

TLRY Financials

1-year income & revenue

Key terms

TLRY Forecasts

analyst rating

  • buy
  • hold
  • sell

We're sorry, but this
information is
temporarily unavailable.

1-year stock price forecast

TLRY Competitors

$ Market cap P/E ratio $ Price 1d change 52-week range

Key terms